Bullish option flow detected in Apellis Pharmaceuticals with 5,044 calls trading, 1.1x expected, and implied vol increasing over 6 points to 96.33%. Aug-23 30 calls and Aug-23 25 calls are the most active options, with total volume in those strikes near 3,300 contracts. The Put/Call Ratio is 0.21. Earnings are expected on November 6th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on APLS:
- Stifel believes GA market is large enough for Apellis’ Syfovre
- Astellas Pharma announces FDA approval of Izervay for GA
- Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apellis downgraded to Neutral from Overweight at JPMorgan
- Cantor biotech/biopharma analysts to hold analyst/industry conference call